Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing.
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Trypanosoma lewisi
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 2005 Jul 08; 225(1):1-26.
View in:
PubMed
subject areas
Animals
Cell Movement
Cell Proliferation
Disease Models, Animal
Gene Amplification
Hepatocyte Growth Factor
Humans
Mice
Mice, Transgenic
Mutation
Neoplasms
Neovascularization, Pathologic
Phenotype
Proto-Oncogene Proteins c-met
authors with profiles
Ravi Salgia